Clinical Evaluation of the AqueSys Implant for the Treatment of ocular hypertension and open angle glaucoma

Active, not recruiting

• Conditions: Ocular hypertension and open angle glaucoma; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12610000021077
• Lead Sponsor: Aquesys Inc

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-01-08
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Subjects with poorly controlled intraocular pressure.

Exclusion Criteria

1.Angle Closure Glaucoma
2.Congenital or other secondary glaucomas developed as a complication of other medical conditions

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Safety and Effectiveness. Effectiveness will be evaluated by comparing baseline intraocular pressure values to postoperative values.[Post operative values taken at 1 day, 1 week, 2 week, 1 month, 3 month, 6 month, 9 month and 1 year.]

Secondary Outcome Measures

Name	Time	Method
Suitability of study procedure for use based on the successful application of the device.[Assessed during operative period.]